Hakan Goker joins Merck Serono VC
This article was originally published in Scrip
Executive Summary
Hakan Goker has joined MS Ventures, the corporate venture capital arm of Merck Serono (Merck KGaA), as a director – effective from the 1 November 2013. Prior to joining the Darmstadt, Germany-based firm Dr Goker was acting as a private consultant. He previously worked at Aescap, but left the venture capital company in March this year.
You may also be interested in...
Six New Molecules By 2030 – J&J’s Neuroscience Strategy
Can neuroscience be precise? Peter Fang, worldwide VP of neuroscience, explains J&J's approach to precision medicine in Alzheimer’s disease, depression and other neurological conditions.
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.